(Q37739424)

22 August 2017

1 reference

title

Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management (English)

1 reference

Chronic prostatitis/chronic pelvic pain syndrome

22 August 2017

0 references

0 references

0 references

1 reference

Adam B Murphy

1

1 reference

PubMed ID

20429665

22 August 2017

Robert B Nadler

series ordinal

2

1 reference

PubMed ID

20429665

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Pharmacotherapy

22 August 2017

1 reference

22 August 2017

11

1 reference

22 August 2017

8

1 reference

22 August 2017

1255-1261

1 reference

Comparison of clinical symptoms scored according to the National Institutes of Health chronic prostatitis symptoms index and assessment of antimicrobial treatment in patients with chronic prostatitis syndrome.

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Diagnosis and treatment of 409 patients with prostatitis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Treatment of chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Epidemiologic risk factors for chronic prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Diagnosis and treatment of chronic abacterial prostatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Long-term results of multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Chronic prostatitis/chronic pelvic pain syndrome: role of alpha blocker therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656561003709748

10.1517/14656561003709748

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20429665